2013
DOI: 10.1039/c3cc39059d
|View full text |Cite
|
Sign up to set email alerts
|

Detecting and delivering platinum anticancer drugs using fluorescent maghemite nanoparticles

Abstract: Rhodamine-embedded maghemite nanoparticles could act as fluorescent drug carriers to track and transport platinum anticancer drugs simultaneously.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
14
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(14 citation statements)
references
References 19 publications
0
14
0
Order By: Relevance
“…8 They can also be used for delivery of drugs such as doxorubicin, platinum compounds, anti-inflammatory drugs, and prodrugs. [9][10][11][12] SPIONs are interesting nanoparticles with clinical potential both in the imaging field and for drug delivery.…”
mentioning
confidence: 99%
“…8 They can also be used for delivery of drugs such as doxorubicin, platinum compounds, anti-inflammatory drugs, and prodrugs. [9][10][11][12] SPIONs are interesting nanoparticles with clinical potential both in the imaging field and for drug delivery.…”
mentioning
confidence: 99%
“…In addition, the fluorescent magnetic–cisplatin conjugates (prepared by Wang et al. ) showed lower cytotoxicity against the A549 cell line but slightly higher (1.35‐fold) cytotoxicity against A549R (cisplatin resistant cell line). An improved cytotoxicity of cisplatin magnetic complexes against tumor cells was achieved by Xing et al., whose magnetite–carboxymethylcellulose–cisplatin clusters exhibited 1.2‐fold (HepG2 cell line) and 3‐fold (HeLa cell line) increases in cytotoxicity, and by Munaweera et al., who improved the cytotoxicity of cisplatin after its incorporation together with a holmium radionuclide into a garnet magnetic nanoparticle (2.8‐fold increase in cytotoxicity against the A549 cell line).…”
Section: Resultsmentioning
confidence: 99%
“…Up to now, severalm agnetic polymeric formulations have been developed for the targeted specific delivery of platinum drugs. [13] Among them, polysaccharides (dextran, [14] alginate, [15] and carboxymethylcellulose (CMC) [16] )s eem to be interesting candidates for stabilizing MNPs. In general, polysaccharides are biocompatible polymers and, moreover,c arboxylated polysaccharides (alginate and CMC) can offer free carboxy groups for both the loading of cisplatin molecules and the binding of other molecules possessing ap rimary or secondary amine group, such as drugs, proteins, and fluorescent labels.…”
Section: Introductionmentioning
confidence: 99%
“…First, the pharmacokinetics of PTX and SRB were studied [37][38][39]. Then, their VE conjugates, PTX-VE and SRB-VE, in the TNE were investigated.…”
Section: Pharmacokinetics Of Ptx Srb Ptx-ve and Srb-vementioning
confidence: 99%